BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 28, 2005
 |  BioCentury  |  Finance

EPS watch

EPS watch

Company 4Q04 EPS est 4Q04 EPS actual Outcome Growth from 4Q03 2/25 cls Wk chg % chg Mcap chg 2/25 Mcap
Actelion (SWX:ATLN) NA CHF1 NA NA CHF 128 CHF 4.2 3% $93.0 $2,835.6
In addition to FY05 revenue guidance of CHF560-CHF580M, ATLN looked out to FY09 and said sales of pulmonary arterial hypertension drug Tracleer could...

Read the full 391 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >